Phase I Trial of Daily Oral Polyphenon E in Patients With Asymptomatic Rai Stage 0 to II Chronic Lymphocytic Leukemia
SHANAFELT, Tait D, CALL, Tim G, YANG, Chung S, JELINEK, Diane F, ERLICHMAN, Charles, KAY, Neil E, ZENT, Clive S, LAPLANT, Betsy, BOWEN, Deborah A, ROOS, Michelle, SECRETO, Charla R, GHOSH, Asish K, KABAT, Brian F, LEE, Mao-Jung
Published in Journal of clinical oncology (10.08.2009)
Published in Journal of clinical oncology (10.08.2009)
Get full text
Journal Article
Chronic lymphocytic leukemia in young (≤ 55 years) patients: a comprehensive analysis of prognostic factors and outcomes
Parikh, Sameer A, Rabe, Kari G, Kay, Neil E, Call, Timothy G, Ding, Wei, Schwager, Susan M, Bowen, Deborah A, Conte, Michael, Jelinek, Diane F, Slager, Susan L, Shanafelt, Tait D
Published in Haematologica (Roma) (01.01.2014)
Published in Haematologica (Roma) (01.01.2014)
Get full text
Journal Article
Validation of a new prognostic index for patients with chronic lymphocytic leukemia
Shanafelt, Tait D., Jenkins, Greg, Call, Timothy G., Zent, Clive S., Slager, Susan, Bowen, Deborah A., Schwager, Susan, Hanson, Curtis A., Jelinek, Diane F., Kay, Neil E.
Published in Cancer (15.01.2009)
Published in Cancer (15.01.2009)
Get full text
Journal Article
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL
Ding, Wei, LaPlant, Betsy R., Call, Timothy G., Parikh, Sameer A., Leis, Jose F., He, Rong, Shanafelt, Tait D., Sinha, Sutapa, Le-Rademacher, Jennifer, Feldman, Andrew L., Habermann, Thomas M., Witzig, Thomas E., Wiseman, Gregory A., Lin, Yi, Asmus, Erik, Nowakowski, Grzegorz S., Conte, Michael J., Bowen, Deborah A., Aitken, Casey N., Van Dyke, Daniel L., Greipp, Patricia T., Liu, Xin, Wu, Xiaosheng, Zhang, Henan, Secreto, Charla R., Tian, Shulan, Braggio, Esteban, Wellik, Linda E., Micallef, Ivana, Viswanatha, David S., Yan, Huihuang, Chanan-Khan, Asher A., Kay, Neil E., Dong, Haidong, Ansell, Stephen M.
Published in Blood (29.06.2017)
Published in Blood (29.06.2017)
Get full text
Journal Article
Ofatumumab monotherapy as a consolidation strategy in patients with previously untreated chronic lymphocytic leukaemia: a phase 2 trial
Strati, Paolo, Lanasa, Mark, Call, Timothy G, Leis, Jose F, Brander, Danielle M, LaPlant, Betsy R, Pettinger, Adam M, Ding, Wei, Parikh, Sameer A, Hanson, Curtis A, Chanan-Khan, Asher A, Bowen, Deborah A, Conte, Michael, Kay, Neil E, Shanafelt, Tait D
Published in The Lancet. Haematology (01.09.2016)
Published in The Lancet. Haematology (01.09.2016)
Get more information
Journal Article
Phase 2 trial of daily, oral polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia
Shanafelt, Tait D., Call, Timothy G., Zent, Clive S., Leis, Jose F., LaPlant, Betsy, Bowen, Deborah A., Roos, Michelle, Laumann, Kristina, Ghosh, Asish K., Lesnick, Connie, Lee, Mao‐Jung, Yang, Chung S., Jelinek, Diane F., Erlichman, Charles, Kay, Neil E.
Published in Cancer (15.01.2013)
Published in Cancer (15.01.2013)
Get full text
Journal Article
Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia
Zent, Clive S., Smith, Brian J., Ballas, Zuhair K., Wooldridge, James E., Link, Brian K., Call, Timothy G., Shanafelt, Tait D., Bowen, Deborah A., Kay, Neil E., Witzig, Thomas E., Weiner, George J.
Published in Leukemia & lymphoma (01.02.2012)
Published in Leukemia & lymphoma (01.02.2012)
Get full text
Journal Article
Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practice
Finnes, Heidi D., Chaffee, Kari G., Call, Timothy G., Ding, Wei, Kenderian, Saad S., Bowen, Deborah A., Conte, Michael, McCullough, Kristen B., Merten, Julianna A., Bartoo, Gabriel T., Smith, Matthew D., Leis, Jose, Chanan-Khan, Asher, Schwager, Susan M., Slager, Susan L., Kay, Neil E., Shanafelt, Tait D., Parikh, Sameer A.
Published in Leukemia & lymphoma (03.06.2017)
Published in Leukemia & lymphoma (03.06.2017)
Get full text
Journal Article
Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
Conte, Michael J., Bowen, Deborah A., Wiseman, Gregory A., Rabe, Kari G., Slager, Susan L., Schwager, Susan M., Call, Timothy G., Viswanatha, David S., Zent, Clive S.
Published in Leukemia & lymphoma (01.09.2014)
Published in Leukemia & lymphoma (01.09.2014)
Get full text
Journal Article
The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma
Zent, Clive S., Ding, Wei, Schwager, Susan M., Reinalda, Megan S., Hoyer, James D., Jelinek, Diane F., Tschumper, Renee C., Bowen, Deborah A., Call, Timothy G., Shanafelt, Tait D., Kay, Neil E., Slager, Susan L.
Published in British journal of haematology (01.06.2008)
Published in British journal of haematology (01.06.2008)
Get full text
Journal Article
Early treatment of high‐risk chronic lymphocytic leukemia with alemtuzumab and rituximab
Zent, Clive S., Call, Timothy G., Shanafelt, Tait D., Tschumper, Renee C., Jelinek, Diane F., Bowen, Deborah A., Secreto, Charla R., LaPlant, Betsy R., Kabat, Brian F., Kay, Neil E.
Published in Cancer (15.10.2008)
Published in Cancer (15.10.2008)
Get full text
Journal Article
Early treatment of high risk chronic lymphocytic leukemia with alemtuzumab, rituximab and poly-(1-6)-beta-glucotriosyl-(1-3)- beta-glucopyranose beta-glucan is well tolerated and achieves high complete remission rates
Zent, Clive S., Call, Timothy G., Bowen, Deborah A., Conte, Michael J., LaPlant, Betsy R., Witzig, Thomas E., Ansell, Stephen M., Weiner, George J.
Published in Leukemia & lymphoma (03.08.2015)
Published in Leukemia & lymphoma (03.08.2015)
Get full text
Journal Article
Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings
Hampel, Paul J., Chaffee, Kari G., King, Rebecca L., Simonetto, Douglas, Larson, Melissa C., Achenbach, Sara, Call, Timothy G., Ding, Wei, Kenderian, Saad S., Leis, Jose F., Chanan‐Khan, Asher A., Bowen, Deborah A., Conte, Michael J., Schwager, Susan M., Hanson, Curtis A., Slager, Susan L., Kay, Neil E., Shanafelt, Tait D., Parikh, Sameer A.
Published in American journal of hematology (01.12.2017)
Published in American journal of hematology (01.12.2017)
Get full text
Journal Article
Prognostic importance of T and NK‐cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia
Palmer, Shanique, Hanson, Curtis A., Zent, Clive S., Porrata, Luis F., LaPlant, Betsy, Geyer, Susan M., Markovic, Svetomir N., Call, Timothy G., Bowen, Deborah A., Jelinek, Diane F., Kay, Neil E., Shanafelt, Tait D.
Published in British journal of haematology (01.06.2008)
Published in British journal of haematology (01.06.2008)
Get full text
Journal Article
Hematologist/oncologist disease‐specific expertise and survival: Lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)
Shanafelt, Tait D., Kay, Neil E., Rabe, Kari G., Inwards, David J., Zent, Clive S., Leis, Jose F., Schwager, Susan M., Thompson, Carrie A., Bowen, Deborah A., Witzig, Thomas E., Slager, Susan L., Call, Timothy G.
Published in Cancer (01.04.2012)
Published in Cancer (01.04.2012)
Get full text
Journal Article
Akt inhibitor MK2206 selectively targets CLL B‐cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis
Ding, Wei, Shanafelt, Tait D., Lesnick, Connie E., Erlichman, Charles, Leis, Jose F., Secreto, Charla, Sassoon, Traci R., Call, Timothy G., Bowen, Deborah A., Conte, Michael, Kumar, Shaji, Kay, Neil E.
Published in British journal of haematology (01.01.2014)
Published in British journal of haematology (01.01.2014)
Get full text
Journal Article
Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with everolimus (RAD001) and alemtuzumab: a Phase I/II study
Zent, Clive S., Bowen, Deborah A., Conte, Michael J., LaPlant, Betsy R., Call, Timothy G.
Published in Leukemia & lymphoma (02.07.2016)
Published in Leukemia & lymphoma (02.07.2016)
Get full text
Journal Article
Chemoimmunotherapy for relapsed/refractory and progressive 17p13‐deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low‐dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells
Zent, Clive S., Taylor, Ronald P., Lindorfer, Margaret A., Beum, Paul V., LaPlant, Betsy, Wu, Wenting, Call, Timothy G., Bowen, Deborah A., Conte, Michael J., Frederick, Lori A., Link, Brian K., Blackwell, Sue E., Veeramani, Suresh, Baig, Nisar A., Viswanatha, David S., Weiner, George J., Witzig, Thomas E.
Published in American journal of hematology (01.07.2014)
Published in American journal of hematology (01.07.2014)
Get full text
Journal Article
Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia
Maddocks‐Christianson, Kami, Slager, Susan L., Zent, Clive S., Reinalda, Megan, Call, Timothy G., Habermann, Thomas M., Bowen, Deborah A., Hoyer, James D., Schwager, Susan, Jelinek, Diane F., Kay, Neil E., Shanafelt, Tait D.
Published in British journal of haematology (01.11.2007)
Published in British journal of haematology (01.11.2007)
Get full text
Journal Article
Cumulative experience and long term follow-up of pentostatin-based chemoimmunotherapy trials for patients with chronic lymphocytic leukemia
Kay, Neil E, LaPlant, Betsy R, Pettinger, Adam M, Call, Timothy G, Leis, Jose F, Ding, Wei, Parikh, Sameer A, Conte, Michael J, Bowen, Deborah A, Shanafelt, Tait D
Published in Expert review of hematology (03.04.2018)
Published in Expert review of hematology (03.04.2018)
Get more information
Journal Article